Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

New research suggests that decreased activity of ELOVL2 -- a key enzyme in lipid metabolism -- accelerates white blood cell aging and alters genes associated with the onset of blood cancers.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

New research finds reduced ELOVL2 enzyme activity speeds up immune cell aging and disrupts genes linked to cancer.

New research reveals that the enzyme HDAC5 plays a critical role in suppressing a gene (Scn4b) that regulates brain activity associated with drug-related memories, which are central to relapse in ...

Prior to the site-specific biotinylation of the rat anti-HRP antibody using mTG ... convenient because it enables the facile assessment of antigen-binding capacity of the immobilized antibody by a ...

Insulin degrading enzyme (IDE) is a dimeric 110 kDa M16A zinc metalloprotease that degrades ... and provides a new path forward towards the development of substrate-specific modulators of IDE activity ...

In new research published in Nature, scientists have produced the first comprehensive atlas of the tiny energy producers in ...

Researchers used machine learning to predict the PAMs of millions of Cas9 enzymes, identifying a set of novel engineered Cas9 enzymes that would have the best on-target activity and specificity.

Researchers have identified that an enzyme involved in lipid metabolism speeds up the immune system changes associated with ...